Browsing by Author "Almeida, E"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- Comparison between skin prick tests and ImmunoCAP ISAC in the determination of sensitisation to aeroallergensPublication . Sousa, N; Almeida, E; Machado, D; Rodrigues, F; Carrapatoso, I; Faria, E; Ribeiro, H; Chieira, C
- Deflazacort: a possible alternative in corticosteroid allergyPublication . Sousa, NG; Faria, E; Carrapatoso, I; Almeida, E; Geraldes, E; Chieira, C
- Diagnosis of peri-operative anaphylaxis: 33 clinical casesPublication . Faria, E; Sousa, N; Vieira, H; Almeida, E; Nunes, M; Chieira, C
- Long-Term Management of RAP Lesions in Clinical Practice: Treatment Efficacy and Predictors of Functional ImprovementPublication . Marques, MF; Marques, JP; Gil, J; Costa, J; Almeida, E; Cachulo, Mz; Pires, I; Figueira, J; Silva, RPURPOSE: To evaluate the long-term efficacy of ranibizumab in the treatment of retinal angiomatous proliferation (RAP) and to identify predictors of functional outcome. METHODS: Retrospective case series comprised 79 eyes of 68 consecutive patients with RAP followed up ≥36 months. Primary end-points were best-corrected visual acuity (BCVA) and central macular thickness (CMT) variation at 36 months and at the last visit. RESULTS: Mean follow-up time was 59.8 ± 16.0 months. All eyes were treated with pro re nata ranibizumab, with (n = 33) or without (n = 46) photodynamic therapy (PDT). Stabilization or improvement in BCVA was observed in 50.6% of the patients at 36 months, and in 40.5% at the end of the follow-up, where 20.3% preserved reading vision. A significant decrease in CMT was observed at 36 months (p < 0.001), but not at the end of the follow-up. Geographic atrophy (GA) was present in 59.5% of the eyes at the final visit. Baseline subretinal fluid was associated with better visual outcomes (p = 0.001). Results of combination treatment with intravitreal ranibizumab and PDT did not significantly differ from ranibizumab monotherapy. CONCLUSION: Modest functional outcomes can be expected from the long-term treatment of RAP lesions in clinical practice, most likely due to the advent of GA. Baseline subretinal fluid positively correlated with final BCVA.
- Síndrome gato-porco: A propósito de um caso clínicoPublication . Sousa, N; Faria, E; Bartolomé, B; Almeida, E; Segorbe-Luís, A
- Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional OutcomePublication . Farinha, C; Marques, JP; Almeida, E; Baltar, A; Santos, AR; Melo, P; Costa, M; Figueira, J; Cachulo, ML; Pires, I; Silva, RTo evaluate long-term results and predictors of efficacy in patients with macular edema due to retinal vein occlusion (RVO) treated with intravitreal ranibizumab in a clinical practice setting.